Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone

BACKGROUND: Colorectal cancer peritoneal metastasis (CPM) confers an exceptionally poor prognosis, and traditional treatment involving systemic chemotherapy (SC) is largely ineffective. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly advoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirnezami, R, Mehta, A M, Chandrakumaran, K, Cecil, T, Moran, B J, Carr, N, Verwaal, V J, Mohamed, F, Mirnezami, A H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200082/
https://www.ncbi.nlm.nih.gov/pubmed/25225906
http://dx.doi.org/10.1038/bjc.2014.419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200082/
https://www.ncbi.nlm.nih.gov/pubmed/25225906
http://dx.doi.org/10.1038/bjc.2014.419

Ejemplares similares